Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5273389
Max Phase: Preclinical
Molecular Formula: C21H21FN6O2
Molecular Weight: 408.44
Associated Items:
ID: ALA5273389
Max Phase: Preclinical
Molecular Formula: C21H21FN6O2
Molecular Weight: 408.44
Associated Items:
Canonical SMILES: Cc1nc(C)c(C(=O)Nc2ccc(F)c(-c3nc4ncc(C(C)(C)C)cn4n3)c2)o1
Standard InChI: InChI=1S/C21H21FN6O2/c1-11-17(30-12(2)24-11)19(29)25-14-6-7-16(22)15(8-14)18-26-20-23-9-13(21(3,4)5)10-28(20)27-18/h6-10H,1-5H3,(H,25,29)
Standard InChI Key: PFTRFULSCDGUFR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 408.44 | Molecular Weight (Monoisotopic): 408.1710 | AlogP: 4.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 98.21 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.39 | CX Basic pKa: | CX LogP: 3.83 | CX LogD: 3.83 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.55 | Np Likeness Score: -2.03 |
1. Aggarwal R, Sumran G.. (2020) An insight on medicinal attributes of 1,2,4-triazoles., 205 [PMID:32771798] [10.1016/j.ejmech.2020.112652] |
Source(1):